AQR Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

AQR Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-161,537	Closed	-$840K	–	2393
2015 Q4	$840K	Buy	161,537 +52,504	+48%	+$305K	﹤0.01%	1653
2015 Q3	$659K	Buy	109,033 +58,601	+116%	+$718K	﹤0.01%	1620
2015 Q2	$796K	Buy	+50,432	New	+$613K	﹤0.01%	1609
2014 Q4	–	Sell	-13,591	Closed	-$130K	–	2803
2014 Q3	$130K	Sell	13,591 -36,600	-73%	-$374K	﹤0.01%	2422
2014 Q2	$580K	Sell	50,191 -33,700	-40%	-$307K	﹤0.01%	1918
2014 Q1	$839K	Buy	83,891 +30,100	+56%	+$435K	﹤0.01%	1773
2013 Q4	$700K	Sell	53,791 -96,789	-64%	-$1.33M	﹤0.01%	1895
2013 Q3	$2.25M	Buy	+150,580	New	+$1.8M	0.01%	1218

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's RPTP Position: Q1 2016 in Review

AQR Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 161,537 shares — an estimated $840K sold.

AQR Capital Management first reported a position in RPTP in Q3 2013 and held it in 8 quarters. The position peaked at $2.25M in Q3 2013. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

AQR Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
AQR Capital Management sold 161,537 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $840K.
AQR Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 8 quarters.
AQR Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $2.25M in Q3 2013.
97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on AQR Capital Management's 13F filing for Q1 2016, filed 16 May 2016.